Press release
Ventricular Assist Devices Market Research Illuminated by New Report
Ventricular assist device, which is also known as VAD, is a mechanically assisted pump which is being used to support heart function and flow of blood in people who have weakened hearts. Ventricular assist device works by taking blood from a lower chamber of the heart and helps pump it to the body & organs similar to a healthy heart. A VAD supports patient’s heart through or after surgery until the heart recovers, while patient is waiting for a heart transplant or if patient is not eligible for a heart transplant. A VAD can also be a long-term solution for patients with cardiac disorders.Request for TOC @ https://www.persistencemarketresearch.com/toc/12223
A VAD has several basic parts such as, a small tube that carries blood out of the heart into a pump; another tube that carries blood from the pump to the blood vessels, which deliver the blood to body. A VAD also has a power source that connects to a control unit which monitors the VAD's functions. If the power is low or the device isn't working well, it gives warnings, or alarms. Some VADs pump blood similarly as heart does, with a pumping action. Other VADs keep up a continuous flow of blood. With a continuous flow VAD, patient might not have a normal pulse, but the body gets the blood it requires.
Initially designed as temporary support to bridge patients to heart transplant, these devices are now available and increasingly being used as lifetime support or destination therapy. Advancements in VAD design, along with advances in surgical and medical management, have permitted VAD patients to return home, and to their communities, with excellent quality of life.
According to Scientific Registry of Transplant Recipients (SRTR) and Organ Procurement and Transplantation Network (OPTN), in 2014, approximately 2,431 heart transplants were conducted and as of February 2015, the number of people awaiting the heart transplantation reached 3,986.
The two basic types of VADs are a left ventricular assist device (LVAD) and a right ventricular assist device (RVAD). If both types are used at the same time, they're called a biventricular assist device (BIVAD). The LVAD is the most common type of VAD. It helps the left ventricle pump blood to the aorta. The aorta is the main artery that carries oxygen-rich blood from the heart to the body. RVADs usually are used only for short-term support of the right ventricle after LVAD surgery or other heart surgery. RVAD helps the right ventricle pump blood to the pulmonary artery. This is the artery that carries blood from the heart to the lungs to pick up oxygen. A BIVAD might be used if both ventricles don't work well enough to meet the body's needs.
VADs have two basic designs. A transcutaneous VAD has its pump and power source located outside of the body. Tubes connect the pump to the heart through small holes in the abdomen. This type of VAD might be used for short-term support during or after surgery. An implantable VAD has its pump located inside of the body and its power source located outside of the body. A cable connects the pump to the power source through a small hole in the abdomen. Implantable VADs are used mainly for people who are waiting for heart transplants or as a long-term solution for people who can't have heart transplants.
On the basis of regional presence, global ventricular assist devices market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to gain more than half of market share of the global ventricular assist devices market due to increasing prevalence of cardiovascular diseases such as hypertension, stroke coronary heart disease, and heart failure. Asia Pacific is expected to be the fastest growing regional market with highest CAGR during the forecast period. Increasing prevalence of cardiovascular disease which in turn leads to stroke, heart failure, and other end-stage cardiovascular diseases and constantly improving healthcare infrastructure are key factors driving the industry growth.
Make an Enquiry @ https://www.persistencemarketresearch.com/samples/12223
Some of the major players in global ventricular assist devices market are Abiomed, Heart Ware International, Thoratec, Berlin Heart, Cardiac Assist, Jarvik Heart, Reliant heart, etc.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ventricular Assist Devices Market Research Illuminated by New Report here
News-ID: 808807 • Views: …
More Releases from Persistence Market Research

Antimicrobial Textile Chemicals Market to Surpass US$ 19.3 Bn by 2032 Fueled by …
According to the latest study by Persistence Market Research, the global antimicrobial textile chemicals market is projected to grow from US$ 12.0 Bn in 2025 to US$ 19.3 Bn by 2032, registering a CAGR of 7.0% during the forecast period. Growing awareness of hygiene, increasing demand for functional and medical textiles, and innovations in performance fabrics are major forces reshaping the industry landscape.
➤Overview of the Market
The antimicrobial textile chemicals market…

Automotive Remote Diagnostics Market to Reach USD 42.1 Billion by 2031, Growing …
The global Automotive Remote Diagnostics Market is experiencing strong momentum, backed by rapid digitization in the automotive sector, the rise of connected vehicles, and the need for real-time vehicle monitoring. According to Persistence Market Research, the market is projected to grow from USD 14.4 billion in 2024 to USD 42.1 billion by 2031, reflecting a robust CAGR of 16.6% during the forecast period. Remote diagnostics has become a key enabler…

Adventure Tourism Market to Reach $1,773.6 Bn by 2032 at 16.1% CAGR Driven by Th …
Overview of the Market
The global adventure tourism market is experiencing rapid transformation as travelers increasingly seek unique, experiential, and adrenaline-fueled activities over traditional leisure tourism. Estimated at US$ 623.7 billion in 2025, the market is projected to surge to US$ 1,773.6 billion by 2032, reflecting an extraordinary CAGR of 16.1%. This exponential growth can be attributed to the rising demand for authentic travel experiences, growing awareness of outdoor recreational opportunities,…

Hexagonal Boron Nitride Market Surpass US$ 1.38 Bn by 2032 with 5.1% CAGR - Pers …
➤Overview of the Market
The global hexagonal boron nitride (h-BN) market is steadily growing as industries demand materials that deliver exceptional thermal stability, lubricity, and electrical insulation. Often referred to as "white graphite," h-BN combines a layered crystalline structure with remarkable chemical inertness, making it indispensable across high-temperature, electrical, and lubrication applications. Industries such as aerospace, automotive, electronics, and metallurgy leverage h-BN for its ability to withstand extreme environments while maintaining…
More Releases for VAD
Ventricular Assist Device (VAD) Market A Look into Growth and Future Trends
The Ventricular Assist Device (VAD) market, a crucial segment of the medical device industry, is witnessing remarkable growth. With a market size of USD 1.59 billion in 2023, the industry is poised for expansion, projected to reach USD 3.08 billion by 2032. This growth trajectory signifies a compound annual growth rate (CAGR) of 7.1% from 2024 to 2032, reflecting the increasing demand for advanced cardiac care solutions.
Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5151
Ventricular…
Fully MagLev Ventricular Assist Device (VAD) Research:CAGR of 11.3% during the f …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2024 latest report "Fully MagLev Ventricular Assist Device (VAD)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030". Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the…
Ventricular Assist Devices (VAD) Market 2021: Global Industry Analysis Report to …
The global ventricular assist device market size was valued at USD 1.7 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 11% from 2021 to 2027.
Ventricular assist devices, also known as VAD, are mechanical-assisted pumps used to support blood flow and heart function in people with impaired heart function. Ventricular assist devices help draw blood from the lower spaces of the heart and…
Latest Trends in Implantable Ventricular Assist Devices (VAD) Market 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Implantable Ventricular Assist Devices (VAD) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Implantable Ventricular Assist Devices (VAD) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market Overview
The Implantable Ventricular Assist Devices (VAD) market report provides a detailed analysis of global market size, regional…
SPECTRAMI Announces VAD Partnership with Cato Networks for Germany
Tel Aviv, Israel, and Frankfurt, Germany – Sep. 11th, 2018 – Cato Networks, a leading provider of global, cloud-based SD-WAN with built-in network security stack, today announced it has signed a distribution agreement with SPECTRAMI for Germany.
Cato Network enables organisations to establish a secure, global SD-WAN, delivered as a service, which is providing the core benefits of SD-WAN while enabling secure direct internet access, SLA-backed connectivity, and seamless extension of…
TITUS Announces VAD Partnership with SPECTRAMI for Netherlands and DACH
Manchester, United Kingdom, and Frankfurt, Germany – Aug. 21th, 2018 – TITUS, a leading provider of data protection solutions, today announced it has signed a distribution agreement with SPECTRAMI for the Netherlands and DACH region.
TITUS’ flexible software enables organisations to meet compliance regulations, standards, and frameworks such as the European Union’s General Data Protection Regulation (GDPR), Financial Market Supervisory Authority (FINMA) in Switzerland, ISO/IEC 27001:2013, NIST Cybersecurity Framework, and many…